Incidence of sight‐threatening retinopathy in Type 1 diabetes in a systematic screening programme

Aim To measure the cumulative incidence of any retinopathy, maculopathy and sight‐threatening diabetic retinopathy (STDR), and calculate optimal screening intervals by retinopathy grade at baseline for patients with Type 1 diabetes attending an established systematic retinal screening programme.

[1]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. , 1984, Ophthalmology.

[2]  J Clowes,et al.  Preservation of sight in diabetes: developing a national risk reduction programme , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[3]  Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. , 1995, Ophthalmology.

[4]  D. DeMets,et al.  The validity of a survey question to study diabetic retinopathy. , 1986, American journal of epidemiology.

[5]  R. Klein,et al.  Diabetic retinopathy as detected using ophthalmoscopy, a nonmydriatic camera and a standard fundus camera. , 1985, Ophthalmology.

[6]  D L DeMets,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. , 1989, Archives of ophthalmology.

[7]  D L DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. , 1989, Ophthalmology.

[8]  E. M. Kohner,et al.  Protocols for screening and treatment of diabetic retinopathy in Europe. , 1991, European journal of ophthalmology.

[9]  P. Summanen,et al.  Detection of retinal neovascularizations using 45 ° and 60 ° photographic fields with varying 45 ° fields simulated on a 60 ° photograph , 2002 .

[10]  E. Agardh,et al.  A 5‐year follow‐up study on the incidence of retinopathy in type 1 diabetes mellitus in relation to medical risk indicators , 1994, Journal of internal medicine.

[11]  T. Sano,et al.  [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.

[12]  J. Scott,et al.  Prevalence of diabetic eye disease in an inner city population: The liverpool diabetic eye study , 1999, Eye.

[13]  R. Klein,et al.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. , 1995, Ophthalmology.

[14]  R. Klein,et al.  The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. , 1994, Archives of ophthalmology.

[15]  M J Buxton,et al.  Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. , 1992, Health economics.

[16]  Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. , 1991, Ophthalmology.

[17]  F L Ferris,et al.  Photocoagulation for diabetic macular edema. , 1987, Archives of ophthalmology.

[18]  N. Nielsen.  Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. , 2009, Acta ophthalmologica.

[19]  C. Burns-Cox,et al.  Blind and partial sight registration in Avon. , 1989, The British journal of ophthalmology.

[20]  Four risk factors for severe visual loss in diabetic retinopathy. The third report from the Diabetic Retinopathy Study. The Diabetic Retinopathy Study Research Group. , 1979, Archives of ophthalmology.

[21]  G. Blankenship,et al.  Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5. , 1981, Developments in ophthalmology.

[22]  L. Groop,et al.  Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study. , 1999, Acta ophthalmologica Scandinavica.

[23]  L. Melton,et al.  Incidence of Diabetic Retinopathy and Blindness: A Population-based Study in Rochester, Minnesota , 1985, Diabetes Care.

[24]  S. Harding,et al.  Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight threatening eye disease: the Liverpool diabetic eye study , 1995, BMJ.

[25]  F. Jónasson,et al.  Active prevention in diabetic eye disease. A 4-year follow-up. , 2009, Acta ophthalmologica Scandinavica.

[26]  R. Klein,et al.  New Management Concepts for Timely Diagnosis of Diabetic Retinopathy Treatable by Photocoagulation , 1987, Diabetes Care.

[27]  Marilyn James,et al.  Cost effectiveness analysis of screening for sight threatening diabetic eye disease , 2000, BMJ : British Medical Journal.

[28]  R. Klein,et al.  The incidence of vision loss in a diabetic population. , 1988, Ophthalmology.

[29]  D. DeMets,et al.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.

[30]  Simon P Harding,et al.  Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study , 2003, The Lancet.

[31]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .